Drug Channels
JANUARY 7, 2025
It's time for Drug Channels annual examination of U.S. brand-name drug pricing. For 2024, average brand-name drugs list prices grew by only 2.3%. Whats more, after adjusting for overall inflation, brand-name drug net prices dropped for an unprecedented seventh consecutive year. The bubble wont vanish overnight.
Drug Channels
NOVEMBER 15, 2024
Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Click here to learn more about NorstellaLinQ , an integrated data asset that combines claims, labs, and EMR data with forecasting, clinical, payer, and commercial intelligence. Read on for their insights. All rights reserved.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Channels
NOVEMBER 4, 2024
Here on Drug Channels , we have long highlighted the boom in provider-administered biosimilars. drug channel system is warping hospitals’ incentives to adopt biosimilars, while simultaneously raising costs for commercial plans. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.
Drug Channels
MAY 21, 2025
The Inflation Reduction Act (IRA) is triggering increases in Medicare beneficiaries spending on their Part B drugs. We find that a growing number of Part B drugs now have inflation-adjusted coinsurance rates that are rising, not falling. Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.
Drug Target Review
JUNE 6, 2025
Image credit: Crystal Eye Media / Shutterstock The role of SPICA and manufacturing capabilities Drug development in the radiopharmaceutical space is particularly resource intensive. Shared goals in cancer drug discovery For all its internal capabilities, RMX does not operate in isolation. This is where the SPICA Center comes in.
Drug Channels
FEBRUARY 26, 2025
On March 18, 2025, Drug Channels Institute will release The 2025 Economic Report on U.S. drug pricing, reimbursement, and dispensing system. prescription drug channels. prescription drug channels. Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.
Drug Channels
JULY 12, 2024
Gavin discusses the three key reasons for duplicate discounts between the 340B Drug Pricing Program and the Medicaid Drug Rebate Program. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. He then explains Oregon’s novel approach to fixing the problem. All rights reserved.
Expert insights. Personalized for you.
90 
Let's personalize your content